Mind Medicine Inc (MNMD) Is Not Likely To Be The Same Tomorrow

After Hours

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.

Stocks Info

Mind Medicine Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Mind Medicine Inc is $599.11M. A total of 3.44 million shares were traded on the day, compared to an average of 1.53M shares.

In the most recent transaction, Barrow Robert sold 19,106 shares of MNMD for 7.43 per share on Dec 26 ’24. After the transaction, the Chief Executive Officer now owns 526,666 company shares. In a previous transaction on Dec 26 ’24, Liao Carrie sold 2,273 shares at 7.43 per share. MNMD shares that Chief Accounting Officer owns now total 97,270.

Among the insiders who sold shares, Karlin Dan disposed of 6,643 shares on Dec 26 ’24 at a per-share price of $7.43. This resulted in the Chief Medical Officer holding 338,013 shares of MNMD after the transaction. In another insider transaction, Sullivan Mark sold 4,519 shares at $7.43 per share on Dec 26 ’24. Company shares held by the Chief Legal Officer now total 173,197.

Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, MNMD has a high of $12.22 and a low of $3.85.

As of this writing, MNMD has an earnings estimate of -$0.28 per share for the current quarter. EPS was calculated based on a consensus of 7.0 estimates, with a high estimate of -$0.14 per share and a lower estimate of -$0.34.

Balance Sheet Annually/Quarterly

As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. MNMD’s latest balance sheet shows that the firm has $133.54M in Cash & Short Term Investments as of fiscal 2021. There were $0.00 in debt and $10.41M in liabilities at the time. Its Book Value Per Share was $3.21, while its Total Shareholder’s Equity was $151.66M.

Analysts Opinion

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for MNMD is Buy with a score of 4.91.

Most Popular

Related Posts